Open AccessDeterminants of Liver Complications Among HIV/Hepatitis B Virus–Coinfected Patients
Author(s) -
Vincent Lo Re,
Craig Newcomb,
Dena M. Carbonari,
Jason Roy,
Keri N. Althoff,
Mari M. Kitahata,
K. Rajender Reddy,
Joseph K. Lim,
Michael J. Silverberg,
Angel M. Mayor,
Michael A. Horberg,
Edward R. Cachay,
Gregory D. Kirk,
Mark Hull,
John Gill,
Timothy R. Sterling,
Jay R. Kostman,
Marion G. Peters,
Richard D. Moore,
Marina B. Klein,
H. Nina Kim
Publication year - 2019
Publication title -
journal of acquired immune deficiency syndromes
Language(s) - English
Resource type - Journals
eISSN - 1944-7884
pISSN - 1525-4135
DOI - 10.1097/qai.0000000000002094
Subject(s) - medicine , liver disease , hazard ratio , gastroenterology , hepatocellular carcinoma , cohort , hepatitis c , hepatitis b virus , retrospective cohort study , proportional hazards model , spontaneous bacterial peritonitis , cohort study , liver cancer , ascites , hepatic encephalopathy , hepatitis c virus , immunology , confidence interval , cirrhosis , virus
Hepatitis B virus (HBV) infection is a leading cause of end-stage liver disease (ESLD) and hepatocellular carcinoma (HCC) in HIV. Factors contributing to the high rates of liver complications among HIV/HBV-coinfected individuals remain unknown.